Biomedical Flows: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 5: | Line 5: | ||
| [[AC7-01|Aerosol deposition in the human upper airways]] || P. Koullapis ''et al.'' || University of Cyprus | | [[AC7-01|Aerosol deposition in the human upper airways]] || P. Koullapis ''et al.'' || University of Cyprus | ||
|- style="background-color:LightGrey;" | |- style="background-color:LightGrey;" | ||
!7- | !7-02 | ||
| [[AC7-02|Airflow in the human upper airways]] || P. Koullapis ''et al.'' || University of Cyprus | | [[AC7-02|Airflow in the human upper airways]] || P. Koullapis ''et al.'' || University of Cyprus | ||
|- style="background-color:LightGrey;" | |||
!7-04 | |||
| [[AC7-04|A pulsatile 3D flow relevant to thoracic hemodynamics: CFD - 4D Flow MRI comparison]] || Morgane Garreau || University of Montpellier, France | |||
|} | |} | ||
Revision as of 11:33, 19 January 2022
| AC | Application Challenges | Contributor | Organisation |
|---|---|---|---|
| 7-01 | Aerosol deposition in the human upper airways | P. Koullapis et al. | University of Cyprus |
| 7-02 | Airflow in the human upper airways | P. Koullapis et al. | University of Cyprus |
| 7-04 | A pulsatile 3D flow relevant to thoracic hemodynamics: CFD - 4D Flow MRI comparison | Morgane Garreau | University of Montpellier, France |